Treatment of Cutaneous Squamous Cell Carcinoma with the Topical Histone Deacetylase Inhibitor Remetinostat

James M. Kilgour; Aatman Shah; Shaundra Eichstadt; Irene Bailey; Sumaira Z. Aasi; Kavita Y. Sarin

doi:10.1001/jamadermatol.2021.4549

Treatment of Cutaneous Squamous Cell Carcinoma with the Topical Histone Deacetylase Inhibitor Remetinostat

James M. Kilgour
, Aatman Shah
, Shaundra Eichstadt
, Irene Bailey
, Sumaira Z. Aasi
, Kavita Y. Sarin

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English
Pages (from-to)	105-107
Number of pages	3
Journal	JAMA Dermatology
Volume	158
Issue number	1
DOIs	https://doi.org/10.1001/jamadermatol.2021.4549
State	Published - Jan 2022

Access to Document

10.1001/jamadermatol.2021.4549

Cite this

@article{f13f653e29154bcf8c76dac81e14769a,

title = "Treatment of Cutaneous Squamous Cell Carcinoma with the Topical Histone Deacetylase Inhibitor Remetinostat",

author = "Kilgour, \{James M.\} and Aatman Shah and Shaundra Eichstadt and Irene Bailey and Aasi, \{Sumaira Z.\} and Sarin, \{Kavita Y.\}",

note = "Funding Information: Funding/Support: Funding for this project was provided by Medivir AB, the Damon Runyon Foundation (Dr Sarin), and the NCI grant 5K23CA211793 (Dr Sarin). Dr Sarin is the D. G. {\textquotedblleft}Mitch{\textquotedblright} Mitchell Clinical Investigator and supported by the Damon Runyon Cancer Research Foundation (CI-104-19). Funding Information: support from Medivir AB during the conduct of the study. Ms Bailey reported grants from Medivir during the conduct of the study. Dr Sarin reported grants from Medivir, the Damon Runyon Cancer Foundation, and the National Institutes of Health/National Cancer Institute (NCI) during the conduct of the study. No other disclosures were reported.",

year = "2022",

month = jan,

doi = "10.1001/jamadermatol.2021.4549",

language = "English",

volume = "158",

pages = "105--107",

journal = "JAMA Dermatology",

issn = "2168-6068",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Treatment of Cutaneous Squamous Cell Carcinoma with the Topical Histone Deacetylase Inhibitor Remetinostat

AU - Kilgour, James M.

AU - Shah, Aatman

AU - Eichstadt, Shaundra

AU - Bailey, Irene

AU - Aasi, Sumaira Z.

AU - Sarin, Kavita Y.

N1 - Funding Information: Funding/Support: Funding for this project was provided by Medivir AB, the Damon Runyon Foundation (Dr Sarin), and the NCI grant 5K23CA211793 (Dr Sarin). Dr Sarin is the D. G. “Mitch” Mitchell Clinical Investigator and supported by the Damon Runyon Cancer Research Foundation (CI-104-19). Funding Information: support from Medivir AB during the conduct of the study. Ms Bailey reported grants from Medivir during the conduct of the study. Dr Sarin reported grants from Medivir, the Damon Runyon Cancer Foundation, and the National Institutes of Health/National Cancer Institute (NCI) during the conduct of the study. No other disclosures were reported.

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85119865402

U2 - 10.1001/jamadermatol.2021.4549

DO - 10.1001/jamadermatol.2021.4549

M3 - Letter

C2 - 34787644

AN - SCOPUS:85119865402

SN - 2168-6068

VL - 158

SP - 105

EP - 107

JO - JAMA Dermatology

JF - JAMA Dermatology

IS - 1

ER -